Alcoholism Clinical Trial
Official title:
Trauma, Stress and Persistence of HPA Dysregulation in Alcoholism
This study, conducted at the University of Texas Southwestern Medical Center and the Parkland
Hospital in Dallas, will examine the stress hormone system of alcohol-dependent people. This
system is weakened in alcohol-addicted people. This study will determine how long it is
weakened, whether other hormone systems are also weakened and whether changes in the hormone
system are associated with previous trauma or stress.
Healthy normal men and men who are alcohol-dependent may be eligible for this study.
Candidates must be between 21 and 60 years of age and have at least a 5-year history of
active alcohol dependence. They are screened with a medical history, blood and urine tests
and questions about alcohol and drug use, psychiatric problems, history of trauma and recent
stress.
Participants undergo the following procedures:
Day 1 - Public Speaking Task
At 6:00 PM subjects have an I.V. line (needle attached to a small plastic tube) inserted into
a vein in each arm to draw blood samples and give medication. They are then given a light
dinner and then lie down and rest. They rinse their mouth out with water and a drop of lemon
juice is placed on their tongue. In 30 to 40 seconds they spit into a funnel attached to a
collecting tube. A blood sample is collected to measure levels of cortisol (a stress hormone)
ACTH (a hormone responsible for the release of cortisol) and neurosteroids (hormones that
affect the brain). Subjects then give a 5-minute speech (telling an ending to a story) and
solve a math problem in front of a small group of people. They are then asked how they are
feeling. Saliva and blood samples are then collected every 10 minutes for the next 60
minutes.
Day 2 - Cosyntropin Study
At 6:30 p.m. subjects have an I.V. line inserted into a vein in each arm. At 7:45 PM and 8:30
PM saliva is collected as described above. Starting at 7:30 PM, blood samples are collected
every 10 minutes until 9:00 PM and then every 20 minutes until 10:00 PM. At 8:00 PM
cosyntropin (a medicine that stimulates production of cortisol) is given through the I.V.
over 1 minute.
Day 3 - oCRH Study
At 6:30 p.m. subjects have an I.V. line inserted into a vein in each arm. At 7:45 PM and 8:30
PM saliva is collected as described above. Starting at 7:30 PM, blood samples are collected
every 10 minutes until 9:00 PM and then every 20 minutes until 10:00 PM. At 8:00 PM ovine CRH
(a medicine that stimulates production of cortisol) is given through the I.V. over 1 minute.
Participants may be asked to repeat these studies 3 months later.
The hypothalamic-pituitary-adrenal (HPA) axis provides a key biologic link between the brain and the body's behavioral and physiologic responses to stress, recovery, and adaptation. Both mental trauma and chronic alcohol use may produce disturbances in the HPA response to stress. Thus, changes in this system during a period when there is no alcohol intake may impair the body's ability to mount an appropriate response to environmental stressors, heightening the probability of additional alcohol intake. However, the relationship between trauma, stress, and HPA axis disturbances requires further study. In this study, the NIH investigators will attempt to determine if the sensitivity of glucocorticoid gene induction varies with stress. Blood samples will be obtained at The University of Texas Southwestern Medical Center (TSMC) in collaboration with the Veteran's Affairs Medical Center (VA) at Dallas, Texas under a protocol and consent forms approved by TSMC IRB. Only samples collected as described in the TSMC protocol will be studied at NIH. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054738 -
CRP and S&A for Inpatient Veterans
|
N/A | |
Completed |
NCT02233738 -
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
|
N/A | |
Completed |
NCT05877807 -
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
|
||
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Completed |
NCT01389297 -
Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery
|
N/A | |
Completed |
NCT00768508 -
Combined Pharmacotherapies for Alcoholism
|
Phase 3 | |
Completed |
NCT01760785 -
Valproate for Mood Swings and Alcohol Use Following Head Injury
|
N/A | |
Completed |
NCT01113164 -
Matching Genotypes and Serotonergic Medications for Alcoholism
|
Phase 1 | |
Completed |
NCT00127231 -
Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women
|
N/A | |
Terminated |
NCT02842528 -
Cognitive Vulnerability Factors in Alcohol-dependence
|
N/A | |
Completed |
NCT00367575 -
An Internet-based Intervention for Problem Drinking
|
N/A | |
Completed |
NCT00223639 -
New Medications to Treat Alcohol Dependence
|
Phase 2 | |
Completed |
NCT00167687 -
Prazosin Alcohol Dependence IVR Study
|
Phase 4 | |
Completed |
NCT00583440 -
12-step Facilitation for the Dually Diagnosed
|
Phase 1/Phase 2 | |
Recruiting |
NCT00447785 -
Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients
|
N/A |